000 01605nam a2200409 i 4500
999 _c287238
_d287238
001 on1112073384
003 OCoLC
005 20191004133613.0
006 m o d f
007 cr |||||||||||
008 190812m20189999dcu ob f000 0 eng c
040 _aPUCPR
_beng
_erda
_epn
_cGPO
_dMvI
042 _apcc
043 _an-us---
074 _a1038-C (online)
086 0 _aY 4.F 49:S.HRG.116-39
099 _aY 4.F 49:S.HRG.116-39
110 1 _aUnited States.
_bCongress.
_bSenate.
_bCommittee on Finance,
245 1 0 _aDrug pricing in America :
_ba prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session, February 28, 2019.
264 1 _aWashington :
_bU.S. Government Publishing Office,
_c2019.
300 _a1 online resource (volumes).
336 _btxt
337 _bc
_2rdamedia
338 _bcr
_2rdacarrier
490 1 _aS. hrg. ;
_v116-39
500 _aCRDP Program record.
588 _aDescription based on online resource; title from PDF, pt. 2, title page (Govinfo website, viewed Aug. 12, 2019).
810 1 _aUnited States.
_bCongress.
_bSenate.
_tS. hrg. ;
_v116-39.
856 4 0 _uhttps://purl.fdlp.gov/GPO/gpo124181
050 4 _aKF26
_b.F5 2019
650 0 _aDrugs
_xPrices
_xGovernment policy
_zUnited States.
650 0 _aPrescription pricing
_zUnited States.
650 0 _aDrugs
_zUnited States
_xCost control.
650 0 _aPharmaceutical industry
_zUnited States.
655 7 _aLegislative hearings.
_2lcgft
942 _2sudocs
_c8